A Comprehensive Review of Contemporary Literature for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer and Their Toxicity
Chung‐Shien Lee, Sandhya Sharma, Emily Miao, Cheryl Mensah, Kevin M. Sullivan, Nagashree Seetharamu
Journal
- ISSN / E-ISSN
- — / —
- DOI
- 10.2147/lctt.s258444 ↗
- Volume · Issue · Pages
- Volume 11 · — · 73-103
- Publisher
- Dove Medical Press Ltd.
- Article URL
- https://doi.org/10.2147/lctt.s258444 ↗
- Article details
- Unverified
Publication date (each date has its type and source)
01 Oct 2020
OpenAlex publication date · source: OpenAlex
| Type | Date | Source |
|---|---|---|
| OpenAlex publication date | 01 Oct 2020 | OpenAlex |
Keywords (as given): epidermal growth factor receptor; EGFR tyrosine kinase inhibitors; non-small cell lung cancer; EGFR mutation; osimertinib; erlotinib; gefitinib; icotinib; afatinib; dacomitinib; drug toxicity management; acquired drug resistance; third-generation TKIs; targeted therapy
HEC Status at Publication Not the journal's current status
HEC Status at PublicationNot conclusive
Historical status could not be conclusively determined.
- HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
Best available information, not a definitive status: HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
- Journal
- Lung Cancer: Targets and Therapy
- Publication date used
- 01 Oct 2020 (OpenAlex publication date)
- Applicable HEC period
- None recorded for this date
- Category
- —
- Recognition status
- Unknown (NO_PERIOD_FOR_DATE)
- Source
- —
- Verification status
- Not available
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.